Molecular profiling and commercial predication assays in ovarian cancer: still not ready for prime time?

Abstract excerpt

Short of early detection to allow curative primary intervention, the other major barrier to further success in treatment of ovarian cancers is matching the best treatment to the proper ovarian cancer type and to the individual patient. There are several decades of experience applying in vitro che...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Commerce
• Share to Molecular Diagnostic Techniques
• Share to Molecular Targeted Therapy